From a blog by VALID advisor Christian Sillaber, Senior Researcher on IT-Security
The European Union’s General Data Protection Regulation (GDPR) came into effect on May 25, 2018. It is already clear that the new law, which is in many respects ground-breaking, is struggling to keep up with the pace of technological change. If this issue is not addressed, the GDPR will undermine citizens’ ability to use blockchain.
The core of the problem is that, in addition to the explicit declaration of the rights of the data subject (access to data, data portability, right to erasure, right to correction etc.), the GDPR also mandates that data controllers and processors abide by the principle of “data protection by design and default”. This means designing services and software with privacy as a foundational consideration rather than as an afterthought or add-on. The implied design requirements and goals seem to be at odds with the fundamental ideas behind blockchain and other emerging distributed ledger technologies — in particular transparency, immutability and egalitarian access to the data.
The GDPR applies to the processing of personal data (Art. 2 para. 1 GDPR), that is, any information relating to an identified or — by the use of additional information — identifiable person (Art. 4 para. 1 GDPR). Although the cryptographic identities used by most participants of public permissionless distributed ledger systems are not directly linked to identified natural persons, it is — under certain circumstances — possible to identify participants through additional information (e.g. correlation of the person’s activities with third party data). Therefore, data stored and processed in most public, permissionless blockchain systems should be considered personal data. Little doubt also remains that territorial applicability can also be established for most distributed ledger systems, as they are either (partially) operated from within the EU or are actively used to process data from data subjects located in the EU.
Public, permissionless distributed ledger systems enable their participants to maintain a public database without the need for a trusted central authority or mutual trust. Any participant may enter or leave the system at any time and, therefore, access the data of the ledger at any time.
Image Credit: Valid
News This Week
WEHI researchers are studying 'nanobodies' – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19. Alpacas produce unique antibodies—called nanobodies—that can [...]
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a [...]
A genetic modification in the ‘coat’ of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers. They say testing people for this and other viral mutations [...]
Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells. Now, researchers reporting in ACS' Nano Letters have designed DNA-based nanogels that only break down and [...]
The new technology behind Pfizer's and Moderna's coronavirus vaccines could be used to prevent everything from heart disease to cancer, experts say. The breakthrough vaccine 'platform' they use transforms the body into a virus-zapping vaccine [...]
Current state-of-the-art techniques have clear limitations when it comes to imaging the smallest nanoparticles, making it difficult for researchers to study viruses and other structures at the molecular level. Scientists from the University of Houston [...]
Virtual patients, vaccines, medicine-making biomachines and microneedles are examples of tech innovation that is meeting the moment to address the global health crisis. Health has been a strong focus for this year’s top 10 [...]
A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective vaccine against the coronavirus. Pfizer said Monday that an early peek at the data on its [...]